Nor Neostigmine
CAS: 16088-19-0
Ref. 3D-RAA08819
| 1g | Descatalogado | ||
| 50mg | Descatalogado | ||
| 100mg | Descatalogado | ||
| 250mg | Descatalogado | ||
| 500mg | Descatalogado |
Información del producto
Nombre:
Nor Neostigmine
Sinónimos:
- 16088-19-0
- 3-(Dimethylamino)Phenyl Dimethylcarbamate
- Carbamic acid, dimethyl-, 3-(dimethylamino)phenyl ester
- Carbamic acid, dimethyl-, m-(dimethylamino)phenyl ester
- Dimethylcarbamic Acid 3-(Dimethylamino)phenyl Ester
- Norneostigmine
- carbamic acid, N,N-dimethyl-, 3-(dimethylamino)phenyl ester
- 3-(Dimethylamino)phenyl N,N-dimethylcarbamate
Descripción:
Nor Neostigmine is a cholinesterase inhibitor, which is used to treat patients with myasthenia gravis. It works by blocking the breakdown of acetylcholine at the neuromuscular junction, thereby increasing its concentration in the synaptic cleft and improving muscle contractions. Nor Neostigmine has been shown to be effective for treatment of diabetic neuropathy and other diseases that result from decreased cholinergic activity. The drug has also been shown to have a beneficial effect on locomotor activity in rats. Nor Neostigmine is not active against human immunodeficiency virus or inflammatory diseases of the intestine.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
208.26 g/mol
Fórmula:
C11H16N2O2
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
